Clinical Centre of Kragujevac
Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease
2012 · Bernard De Bruyne, Nico H.J. Pijls, et al. · New England Journal of Medicine
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
2012 · Jeffrey Cohen, Alasdair Coles, et al. · The Lancet
Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease
2014 · Bernard De Bruyne, William F. Fearon, et al. · New England Journal of Medicine